Oceansbio Co. Ltd. engages in the production of the Transcutaneous auricular Vagus Nerve Stimulation (TaVNS), which is used to aid people suffering from neurological disorders. The company was founded on July 20, 2018 and is headquartered in Changwon-si, South Korea.